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Male-Specific Increase in the Prevalence of Atrial 
Fibrillation, 1976-94: The Copenhagen City Heart Study 
Jens Friberg Henrik Scharling, Niels Gadsball, Gorm B. Jensen, The Copenhagen City 
Heart Study, Copenhagen, Denmark, Bispebjerg University Hospital, Copenhagen, 
Denmark 
Background: Atrial fibrillation (AF) is associated with increased morbidity and mortality. 
Yet, there is a scarcity of data describing the prevalence of AF in the general population. 
With data from The Copenhagen City Heart Study we studied the secular changes in the 
prevalence of atrial fibrillation from 1976 to 1994 in a random population sample of per- 
sons aged 50-69 years. 
Methods: The Copenhagen City Heart Study is a prospective population-based cohort 
study. The prevalence rates of AF, diagnosed from ECGs. were determined in 8,606 per- 
sons examined in 1976-78. 8,943 persons examined in 1981-63 and 6,733 persons 
examined in 1991-94. Changes in AF prevalence were estimated by using the general- 
ized estimating equation method. 
Results: 327 cases of AF were identified (76 cases in 1976-78, 102 in 1981.63 and 149 
in 1991-94). In men, the age-standardized prevalence of AF increased from 1.4% in 
1976-78 (OR: 1.0, referencevalue) to 1.9% in 1961-83 (OR: 1.6; 95% Cl: 1.1-2.1) and to 
3.3% in 1991-94 (OR: 2.3; Cl: 1.6-3.4, p<O.O005, adjusted for age). In women, the age- 
standardized prevalence of AF tended to decrease with time from 1.4% in 1976-78 to 
1.0% in 1981-83 and to 1.1% in 1991-94 (p=O.ll). After adjusting for changes in predis- 
posing conditions such as arterial hypertension. prior myocardial infarction, diabetes mel- 
litus as well as body weight and height, the increase in the prevalence of AF in men 
remained significant (OR: 1.9; Cl: 1.3-2.8. p=O.O02). 
Conclusion: The age-adjusted prevalence of AF in the male population more than dou- 
bled from 1976 to 1994, whereas no change Occurred in women. The responsible fac- 
tor(s) for the sex-specific increase in this common arrhythmia is yet to be identified. 
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1211 MP-169 Three-Dimensional Imaging of the Left Atrium and 
Pulmonary Veins: Computed Tomography or Magnetic 
Resonance Imaging? 
David Schwartzman, Joan M. Lacomis, Atrial Arrhythmia Center, University of Pittsburgh, 
Pittsburgh, PA 
BACKGROUND: Three-dimensional (3D) imaging of the left atrium (LA) and distal pul- 
monary veins (PV) has proven valuable for pre and post-operative management of 
patients undergoing left atrial catheter ablation in the quest for control of atrial fibrillation. 
To achieve this goal, computed tomography (CT) and magnetic resonance imaging 
(MRI) have each bean utilized. A direct comparison of these techniques has not been 
reported. METHODS: 22 patients referred for catheter ablation undenvent both MRI and 
CT preoperatively (same day): CT: after an intravenous bolus injection of Optiray, mul- 
tidetector CT (General Electric (GE] Lightspeed Plus) images were obtained during peak 
LA filling; MRI: after a bolus injection of gadolinium, MRI (GE Signa 1.5T L&9.0) images 
wars obtained during peak LA filling. For both CT and MRI, 3D image (intra and extraa- 
trial vantages) reconstruction of source images was achieved using GE Advantage soft- 
ware. LA and PV dimensions, PV multiplicity and atriovenous junction morphologic detail 
were compared. RESULTS: For both techniques, proper timing of imaging after the con- 
trast agent bolus was important; in this regard, although the task was more easily accom- 
plished with CT, the gadolinium bolus could be repeated but the Optiray could not. Image 
acquisition time was significantly shorter with CT: this was correlated with better patient 
tolerance. Image processing times were similar. Characterization of LA and PV dimen- 
sions demonstrated no significant differences between imaging techniques. Character- 
ization of PV multiplicity and individual atriovenous junction morphology was successfully 
achieved with both techniques, but the identification of dependent lung lobes was much 
more straightfoward with CT. Only CT penined identification of pulmonary parenchymal 
abnormalities. CONCLUSIONS: For characterization of LA and PV anatomy, CT and 
MRI provided similar information. However, CT image acquisition was faster (cheaper), 
easier and better tolerated, and incidental but clinically important pulmonary paranchy- 
mal abnormalities were not uncommon. Based on these features, our current practice is 
to usa CT in the absence of a contraindication to iodinated contrast. 
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121 lMP-170 Can the Left Atrial Appendage Be Safeiy,Closed Without 
Removal? 
David P. Krum, John Hare, Nicholas D. Georgakopoulos, Ryan Cooley, Masood Akhtar, 
Jasbir Sra, Aurora Sinai/St. Luke’s Medical Centers, UW Medical School-Milwaukee 
Clinical Campus, Milwaukee, WI 
Background: Closure of the left atrial appendage (LAA) may reduce the risk of throm- 
boembolic events in patients with atrial fibrillation (AF). We tested the safety of LAA clo- 
sure without removal in a chronic canine study. Methods: Following baseline 
transesophageal echocardiography (TEE), the left atrial appendage was closed using a 
staple (4 dogs) or tied (4 dogs), without removal. The dogs then recovered for three 
months. After the recovery period, the TEE was repeated, the animals were sacrificed 
and the atria were examined visually and histologically. Results: Eight dogs recovered 
for 91k4.1 days after LAA closure. At baseline, the mean LAA length and width were 
3.21*0.31 and 1.79eO.21 cm respectively. The mean inward and outward flow velocities 
were 50.0+12.9 and 51.2*10.0 cm/set respectively. Because the LAA was closed in all 8 
dogs, the above parameters were not measurable upon follow-up. No thrombi were seen 
with TEE or during the necropsy. Scar tissue was seen on the endocardium covering the 
opening into the left atrial appendage. Necrotic or gangrenous tissue in the LAA was not 
observed. Conclusion: LAA closure without removal, using a minimally invasive 
approach such as thoracoscopy, may be a safe and effective way to reduce the risk of 
thromboembolic events in patients with AF who are not candidates for anticoagulation 
therapy. 
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1211 MP-171 Low Incidence of Pulmonary Vein Stenosis Following 
Ostial Pulmonary Vein Ablation 
RitsushiKato, Lars Lickfen, Glenn Meininger, Timm Dickfeld, Ronald D. Berger. Henry R. 
Halperin, Hugh Calkins, Johns Hopkins Hospital, Baltimore, MD 
Pulmonary vein (PV) isolation has been demonstrated to be a useful treatment for 
patients (pts) with paroxysmal atrial fibrillation (PAF). However, PV stenosis following 
catheter ablation is still an important complication, particularly when ablation is per- 
formed deep within the PV. The purpose of this study was to evaluate the characteristics 
and incidence of PV stenosis following ostial PV ablation. 
Methods: Thirty pts with PAF underwent ostial PV ablation using an irrigated ablation 
system(Chili) with Lasso catheter guidance. All pts underwent gadolinium enhanced 
MRA prior to their procedure using 1.5 T MRI system and 20 pts also underwent 2 
months F/U MRA. Three-Dimensional reconstruction images were taken using long axis 
oblique view of each PV for assessment of diameter reduction. A stenosis was defined 
as a narrowing of the PV diameter by greater or equal to 3 mm. The severity of stenosis 
was categorized as mild (~50%). moderate (50 - 70 %), or severe (> 70 %). Pulmonary 
vein stenoses were also classified as being concentric or eccentric. 
Results: The incidence of PV stenosis was evaluated in 64 veins (20 patients). The 
resultant severity of stenosis when normalized to the pulmonary vein diameter was cate- 
gorized as severe in one vein (RSPV,1.6%), moderate in one vein (LIPV, 1.6%), and mild 
in 14 veins (6 LSPV.4 RSPV, 3 LIPV, and 1 long left common trunk, 21.9%). The average 
length, minlmum diameter and reduced diameter of narrowed segment were 15.4 * 5.2 
mm, 10.6 * 3.1 mm, 5.2 * 2.3 mm in patients with mild and moderate narrowings and 14 
mm, 3 mm, 9 mm in the patient with a severe stenosis, respectively. An eccentric narrow- 
ing was seen in 6 veins and was usually distal to the pulmonary vein ostium. A concentric 
narrowing was seen in 10 veins and typically involved the ostium. All patients were 
asymptomatic and none required treatment. 
Conclusions: The results of this study reveal that ostial PV ablation using an irrigated RF 
ablation system is associated with a low (c2%)incidence of moderate or severe PV 
stenosis. These results also confirm the value of MRA for monitoring for this complication 
followlng PV ablation procedures. 
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121 IMP-172 Markers of Inflammation, Myocardiai Damage, and 
Tissue Healing After High-Energy Radiofrequency 
Ablation of Atriai Arrhythmias 
Martina Brueckmann. Christian Wolpert. Thomas Bertsch. Tim Sueselbeck, Carlos 
Jaramillo, Michael Neumaier. Guenter Huhle, Martin Borggrefe, Karl K. Haase. University 
Hospital of Mannheim. Mannheim, Germany 
Background: Radiofrequency ablation is associated with a localized endomyocardial 
necrosis, which may result in the release of biochemical markers of necrosis and inflam- 
mation. It was the aim of this study to determine the time-course of several markers of 
myocardial damage, inflammation and tissue reparation in patients before and after 
radiofrequency catheter ablation. 
Patients and Methods: Blood samples were taken from 13 patients with atrial flutter 
(n=5), atrioventricular nodal reenhy tachycardia (AVNRT; n=5) and Wolf-Parkinson- 
White syndrome (WPW; n=3) undergoing radiofrequency ablation. Blood was taken from 
a peripheral vein before ablation (day 0, baseline), at day 1 and 120 days after ablation. 
The proinflammatory marker interleukin-6 (IL-6) as well as metalloproteinase-9 (MMP-B), 
a marker for myocardial healing, were measured by Enzyme-linked immunosorbent 
assays (ELISA). Troponin I (TNI) and myoglobin, markers of myocardial damage, were 
determined by a h&erogenous calorimetric immunoassay (TNI) or microparticle enzyme 
immunoassay (myoglobin). Statistical analysis was performed by student‘s t-test for sin- 
gle comparisons. For multiple comparisons an analysis of variance was performed 
(ANOVA) followed by the Mann-Whitney-test. 
Results: Levels of IL-6, TNI, myoglobin and MMP-9 were significantly elevated on day 1 
after ablation compared to baseline levels before ablation (pc 0.05). Five of the 13 
patients had cardiac troponin levels greater than the threshold of minor myocardial dam- 
age (>O.l!Z+~g!l). Whereas levels of IL-6 returned to basal levels after 120 days, the 
plasma level of MMP-9 was still elevated on day 120 compared to values before ablation 
(p=o.o21). 
Conclusion: Markers of inflammation, myocardial damage and wound healing are 
increased in patients who undergo radiofrequency ablation. MMP-9, a marker for myo- 
cardial healing is still elevated 120 days after the procedure, suggesting that radiofre- 
quency ablation induces tissue damage leading to a long-term process of reparation. 
